Landscape Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-38,514
Closed -$3.34M 810
2026
Q1
$3.34M Buy
38,514
+15,988
+71% +$1.53M 0.21% 150
2025
Q4
$2.16M Buy
22,526
+17,056
+312% +$1.66M 0.15% 212
2025
Q3
$521K Buy
+5,470
New +$503K 0.03% 451
2022
Q4
Sell
-23,079
Closed -$1.86M 908
2022
Q3
$1.86M Buy
23,079
+9,475
+70% +$852K 0.24% 81
2022
Q2
$1.22M Buy
13,604
+10,022
+280% +$1.02M 0.16% 110
2022
Q1
$397K Buy
+3,582
New +$378K 0.05% 324
2021
Q2
Sell
-9,310
Closed -$1.1M 663
2021
Q1
$1.1M Buy
+9,310
New +$1.09M 0.17% 107
2019
Q2
Sell
-3,476
Closed -$317K 706
2019
Q1
$317K Buy
3,476
+979
+39% +$87.6K 0.03% 518
2018
Q4
$227K Buy
+2,497
New +$233K 0.02% 739
2017
Q4
Sell
-19,293
Closed -$1.5M 707
2017
Q3
$1.5M Buy
+19,293
New +$1.6M 0.15% 137

Other funds holding MDT

Landscape Capital Management's MDT Position: Q2 2026 in Review

Landscape Capital Management sold out of Medtronic (MDT) in Q2 2026, closing a stake of 38,514 shares — an estimated $3.34M sold.

Landscape Capital Management first reported a position in MDT in Q3 2017 and held it in 10 quarters. The position peaked at $3.34M in Q1 2026. 2,140 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Landscape Capital Management reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • Landscape Capital Management sold 38,514 Medtronic shares in Q2 2026, an estimated $3.34M.
  • Landscape Capital Management first reported a position in Medtronic in Q3 2017 and held it in 10 quarters.
  • Landscape Capital Management's Medtronic position peaked at $3.34M in Q1 2026.
  • 2,140 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Landscape Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.